Antimicrobial Drug Resistance Clinical and Epidemiological Aspects, Volume 2 /

The two volumes included in Antimicrobial Drug Resistance, Second Edition is an updated, comprehensive and multidisciplinary reference covering the area of antimicrobial drug resistance in bacteria, fungi, viruses, and parasites from basic science, clinical, and epidemiological perspectives. This ne...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Mayers, Douglas L. (Επιμελητής έκδοσης), Sobel, Jack D. (Επιμελητής έκδοσης), Ouellette, Marc (Επιμελητής έκδοσης), Kaye, Keith S. (Επιμελητής έκδοσης), Marchaim, Dror (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
Έκδοση:2nd ed. 2017.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • History of Drug-Resistant Microbes
  • Evolutionary Biology of Drug Resistance
  • Pharmacology of Drug Resistance
  • Drug Development for Drug-Resistant Pathogens
  • Genetic Mechanisms of Transfer of Drug Resistance
  • Mutations as a Basis of Antimicrobial Resistance
  • Altered Drug Targets
  • Enzymatic Modification of Drugs
  • Reduced Drug Penetration
  • Active Efflux Mechanism
  • Biofilms
  • Beta-Lactamases
  • Penicillin Binding Proteins
  • Aminoglycosides
  • Tetracyclines and ChloramphenicolQuinolones
  • Plasmid Mediated Quinolone Resistance to Macrolides, Lincosamides, and Streptogramins
  • Mechanisms of Resistance in Metronidazole
  • Glycopeptide-resistance in eneterococci
  • Daptomycin Resistance
  • Oxazolidinones
  • PolymyxinsSulfonamides and Trimethoprim
  • Antimycobacterial Agents
  • Amphotericin (Polyenes)
  • Azoles
  • Flucytosine
  • Echinocandins
  • Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
  • Herpes Nucleoside Drugs
  • Influenza Drugs
  • HIV Nucleoside Drugs
  • HIV Non-Nucleoside Drugs
  • HIV Protease Inhibitors
  • HIV Entry Inhibitors
  • HIV Integrase Inhibitors
  • Hepatitis B
  • Hepatitis C
  • Agents for anaerobic protozoa
  • Antimalarial Agents
  • Agents for Leishmania
  • Agents for Trypanosomes
  • Agents for Toxoplasma
  • Agents for Cryptosporidium
  • Agents against Nematodes
  • Agents against Trematodes and Cestodes
  • Agents against Ectoparasites.